Business Context and Reporting Period
Company: HealthStream, Inc. (HSTM)
Filing Type: Form 8-K (Current Report)
Date of Report: September 11, 2026
Event Date: September 11, 2026 (Agreement); September 14, 2026 (Closing)
Context: The Company entered into a Securities Purchase Agreement and a Registration Rights Agreement with WJRJJ Ventures, LLC ("Investor") and its CEO/Chairman, Robert A. Frist, Jr. ("Selling Shareholder"). The transaction is classified as a related-party transaction due to shared interests in Empath Nursing, Inc.
Key Financial Metrics and Transaction Details
| Metric | Value |
|---|---|
| Total Shares Issued/Sold | 1,500,000 shares |
| Shares Issued by Company | 1,355,932 shares |
| Shares Sold by CEO | 144,068 shares |
| Purchase Price Per Share | $29.50 |
| Proceeds to Company | Approximately $40.0 million |
| Proceeds to Selling Shareholder | Approximately $4.25 million |
| Total Transaction Value | Approximately $44.25 million |
Note: This filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company's operations.
Material Changes and Related-Party Nature
- Capital Structure Change: The Company issued 1,355,932 new shares of common stock, resulting in dilution for existing shareholders.
- Related-Party Transaction: The Investor (WJRJJ Ventures, LLC) and the Company both hold significant interests in Empath Nursing, Inc. The Company owns approximately 5% of Empath Nursing, while the Investor owns approximately 42%. Willis Johnson, the owner of the Investor, sits on Empath Nursing's board.
- Approval Process: The transaction was reviewed and approved by the Company's Audit Committee and disinterested Board members. CEO Robert A. Frist, Jr. abstained from voting.
- Standstill Agreement: The Investor is subject to standstill obligations restricting certain actions for 12 months following the Closing Date.
Guidance, Outlook, and Use of Proceeds
Use of Proceeds: The Company intends to use the net proceeds of approximately $40.0 million for general corporate purposes, including:
- Continued investment in its solutions.
- Working capital.
- Potential acquisitions.
- Other strategic initiatives.
Registration Rights: The Investor has the right to request the Company file a registration statement for the resale of shares. The Company must file within 45 days of request and use commercially reasonable efforts to have it declared effective within 75 days (if reviewed) or 5 business days (if not reviewed).
Risks and Forward-Looking Statements: The filing includes standard disclaimers that forward-looking statements regarding the use of proceeds are subject to risks and uncertainties. Actual results may differ materially from expectations.
Key Facts for Investor Verification
- Dilution Impact: Verify the impact of the issuance of 1,355,932 new shares on existing shareholder ownership percentages.
- Related-Party Conflicts: Review the strategic partnership with Empath Nursing, Inc. to understand the economic benefits shared and the rationale for the Investor's involvement.
- CEO Liquidity: Note that CEO Robert A. Frist, Jr. sold 144,068 shares for approximately $4.25 million as part of this transaction.
- Future Dilution Risk: Monitor the Registration Rights Agreement, as the Investor may seek to register the shares for public resale, potentially affecting the stock price.
- Exemption Reliance: Confirm that the shares were issued under Section 4(a)(2) of the Securities Act and are not currently registered for public resale.